[HTML] sciencedirect.com

[HTML][HTML] Advances in PSMA theranostics

TM Jeitner, JW Babich, JM Kelly - Translational Oncology, 2022 - Elsevier
The validation of prostate specific membrane antigen (PSMA) as a molecular target in
metastatic castration-resistant prostate cancer has stimulated the development of multiple …
被引用次数：41 相关文章

Advances in PSMA theranostics

TM Jeitner, JW Babich, JM Kelly - Translational oncology, 2022 - pubmed.ncbi.nlm.nih.gov
The validation of prostate specific membrane antigen (PSMA) as a molecular target in
metastatic castration-resistant prostate cancer has stimulated the development of multiple …
[HTML] nih.gov

[HTML][HTML] Advances in PSMA theranostics

TM Jeitner, JW Babich, JM Kelly - Translational Oncology, 2022 - ncbi.nlm.nih.gov
The validation of prostate specific membrane antigen (PSMA) as a molecular target in
metastatic castration-resistant prostate cancer has stimulated the development of multiple …

Advances in PSMA theranostics.

TM Jeitner, JW Babich, JM Kelly - Translational Oncology, 2022 - europepmc.org
The validation of prostate specific membrane antigen (PSMA) as a molecular target in
metastatic castration-resistant prostate cancer has stimulated the development of multiple …